The Australia Pharmaceutical Packaging Market was valued at $4116.1 Million in 2025 and projected to reach to $9231.4 Million by 2030, representing a compound annual growth rate of 17.5%. Australia's pharmaceutical packaging market is poised for sustained growth through 2030, driven by escalating demand for sophisticated packaging technologies that meet stringent regulatory standards and protect sensitive pharmaceutical products.
Australia's pharmaceutical packaging market is expanding at 17.5% CAGR, significantly outpacing the global rate of 15.8%, demonstrating the country's accelerating demand for advanced packaging solutions in the pharmaceutical sector.
The Australian market is valued at $4,116.1 million in 2025 and is projected to more than double to $9,231.4 million by 2030, reflecting strong investment and infrastructure development in the region.
Australia is strengthening its position as a key player in the Asia Pacific pharmaceutical sector, driven by regulatory compliance requirements, increased domestic manufacturing, and growing export opportunities.
Increasing healthcare expenditure, aging population demographics, and expansion of biopharmaceutical production in Australia are driving robust demand for innovative and compliant packaging solutions.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PREFILLED SYRINGES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 15.8% from 2025 to 2030 |
| Largest Segment | INJECTABLE (Drug Delivery) |
| Market Size Base Year (Billions) | ~USD 174.86 (2025) |
| Revenue Forecast (Billions) | ~USD 364.11 (2030) |
| Segments Covered | Raw Material, Drug Delivery, Type, Packaging Type, Drug Delivery Mode |
5 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| TASNEE | Saudi Arabia | Public Company | Petrochemicals (PE, PP compounds, acrylics, solvents),Metallurgy (titanium sponge, slag, pig iron, lead),Downstream plastics (BOPP films, pipes, pallets, agrifilm, sheets, liners), |
| LG CHEM LTD. | South Korea | Public Company | Ethylene- and propylene-based synthetic resins,Styrene-based resins and polycarbonate,Advanced materials and battery-related chemistries, |
| BOBST GROUP SA | Switzerland | Private Company | Folding carton converting (flatbed die-cutters, folder-gluers, related tooling and services),Corrugated board equipment (flexo printing, rotary die-cutters, folder-gluers, converting lines),Flexible packaging and label equipment (vacuum metallizers, coating/laminating, CI/inline flexo, gravure, digital), |
| GERRESHEIMER AG | Germany | Public Company | Primary Packaging Glass (vials, cartridges, ampoules, flacons),Plastics & Devices (syringes, bottles, closures, medical disposables),Advanced Technologies & Drug Delivery Devices, |
| SCHOTT AG | Germany | Public Company | Prefillable glass syringes (syriQ portfolio),Pharmaceutical glass vials (adaptiQ, EVERIC family),Cartridges (cartriQ and related), |
| APTARGROUP, INC. | United States | Public Company | Pharma (drug delivery, elastomeric components, active material science, digital health),Beauty (fragrance, facial skincare, color cosmetics dispensing),Closures (food, beverage, personal and home care closures and aerosol valves), |
| BD | United States | Public Company | |
| WESTROCK COMPANY | United States | Private Company | Consumer packaging solutions,Corrugated packaging solutions,Merchandising display solutions, |
TASNEE is a Saudi Arabian public company founded in 1984 with 7,000 employees, operating in the petrochemicals and industrial materials industry.
LG Chem Ltd. is a South Korean public company founded in 1947 with 14,019 employees, specializing in chemicals, advanced materials, and energy solutions.
Bobst Group SA is a Swiss private company founded in 1890 with 6,314 employees, manufacturing machinery and equipment for the packaging and printing industries.
Gerresheimer AG is a German public company founded in 1864 with 13,528 employees, manufacturing specialty glass and plastic packaging for pharmaceuticals and cosmetics.
Schott AG is a German public company founded in 1884 with 4,839 employees, producing specialty glass and glass-ceramics for various industrial applications.
AptarGroup, Inc. is a United States public company founded in 1992 with 14,000 employees, manufacturing dispensing systems and packaging solutions for beauty, personal care, and pharmaceutical markets.
BD (Becton, Dickinson and Company) is a United States public company founded in 1897 with 72,000 employees, specializing in medical devices, diagnostics, and laboratory equipment.
WestRock Company is a United States private company founded in 2018 with 56,100 employees, operating as a major manufacturer of paper and packaging products.
Australia's pharmaceutical packaging market is valued at $4,116.1 million in 2025 and is projected to grow to $9,231.4 million by 2030.
Australia's pharmaceutical packaging market is growing at a compound annual growth rate (CAGR) of 17.5% from 2025 to 2030.
Australia's market growth is driven by regulatory compliance requirements, biopharmaceutical manufacturing expansion, advanced drug delivery demand, and sustainability initiatives.
Australia's 17.5% CAGR significantly outpaces the global pharmaceutical packaging market CAGR of 15.8%, reflecting Australia's strong regional position.
Australia's market is seeing increased adoption of sustainable materials, smart packaging technologies, and advanced compliance solutions aligned with TGA standards.
The study involved four major activities to estimate the current size of the global pharmaceutical packaging market. Exhaustive secondary research was carried out to collect information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of pharmaceutical packaging through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the pharmaceutical packaging market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.
The market for the companies offering pharmaceutical packaging is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various secondary sources, such as Business Standard, Bloomberg, World Bank, and Factiva, were referred to in order to identify and collect information for this study on the pharmaceutical packaging market. In the secondary research process, various secondary sources were referred to identify and collect information related to the study. Secondary sources included annual reports, press releases, and investor presentations, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.
In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the pharmaceutical packaging market. After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of pharmaceutical packaging offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.
Notes: Other designations include sales, marketing, and product managers.
Tier 1: Revenues greater than USD 1 Billion; Tier 2: Revenues between USD 500 million and USD 1
Billion; and Tier 3: Revenues less than USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
The top-down and bottom-up approaches were used to estimate and validate the size of the global pharmaceutical packaging market. These approaches were also used extensively to estimate the size of various dependent market segments. The research methodology used to estimate the market size included the following:

After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Pharmaceutical packaging pertains to the materials and systems designed to protect, preserve, and deliver pharmaceutical products for oral, injectable, inhalation, and topical drug delivery modalities. It plays an important role in the stability and sterility of a drug, avoids contamination, and provides accurate dosing for the life of the product. Pharmaceutical packaging denotes the numerous varieties of available options, like plastic bottles, blister packs, vials, ampoules, prefillable syringes, tubes, pouches, and cartons to meet drug formulation requirements and regulatory obligations. Some of the significant functionalities of pharmaceutical packaging include moisture, oxygen, and light barrier protection, tamper evidence, patient convenience, and functionality with active pharmaceutical ingredients (APIs).
Areas of interest include ISO 15378 relating specifically to primary packaging materials, ISO 9001 regarding quality management systems, and GMP compliance. The DSCSA and the EU FMD identified serialized, tracking, and anti-counterfeiting programs, creating an opportunity for the packaging industry to help with drug quality and patient safety.
With the given market data, MarketsandMarkets offers customizations according to client-specific needs.
The following customization options are available for the pharmaceutical packaging market report:
Full forecast, segment splits, and company analysis for all Pharmaceutical Packaging Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report